|Mr. Andrew Christopher Meredith BSc (Hons)||Chief Exec. Officer and Exec. Director||N/A||N/A||50|
|Ms. Mary G. Tavener ACMA, MCT, BA (Hons) Chem (Oxon)||Chief Financial Officer, Company Sec. and Director||N/A||N/A||55|
|Mr. Pieter van Hoof MEng||Group Operations Director||N/A||N/A||44|
|Ms. Cathy Tomlinson||Group HR Director||N/A||N/A||N/A|
|Brian Dowd||Head of US Commercial Team||N/A||N/A||N/A|
Advanced Medical Solutions Group plc, together with its subsidiaries, designs, develops, manufactures, and distributes natural and synthetic polymers for use in advanced woundcare dressings worldwide. It operates through Branded Direct, Branded Distributed, Original Equipment Manufacturer, and Bulk Materials segments. The company offers tissue adhesive products under the LiquiBand brand for medical applications; advanced woundcare products under the ActivHeal brand for use in hospitals, nursing homes, and community care settings; and surgical sutures, haemostats, infection control products, and dental biomaterials for surgical disciplines in hospitals, ambulatories, private practices, and dental settings under the RESORBA brand. It also provides bulk materials, including foams, hydrocolloids, fibers, and pattern coated films to third party converters and partners, as well as collagens and hydrogels. The company was founded in 1991 and is headquartered in Winsford, the United Kingdom.
Advanced Medical Solutions Group plc’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.